该患者是否患有急性高山病?理性临床检查系统综述
该系统综述评估急性高山病(AMS)诊断工具的准确性,以Lake Louise问卷评分(LLQS)≥5为参考标准。共纳入91篇文章(66 944名参与者)进行患病率分析,14篇(1858名参与者)比较至少2种工具。VAS(O)、AMS-C和CFS与LLQS≥5的测试特征相似,CFS最简单实用。
要点
- 海拔每升高1000米(2500米以上),AMS患病率增加13%(95%CI 9.5%-17%)。
- VAS(O)、AMS-C和CFS与LLQS≥5的阳性似然比范围3.2-8.2,特异性67%-92%。
- CFS日常活动中度至重度受限的阳性似然比为3.2(95%CI 1.4-7.2),特异性67%。
核心结论
- 急性高山病患病率随海拔升高而增加。
- VAS(O)、AMS-C和CFS与LLQS≥5的测试特征相似。
- 临床功能评分(CFS)是临床和旅行环境中最简单的工具。
研究设计与样本
- 系统综述,检索MEDLINE和EMBASE从建库至2017年5月,识别1245篇出版物。
- 91篇文章(66 944名参与者)用于患病率分析,14篇文章(1858名参与者)比较至少2种工具。
- 以LLQS≥5为参考标准,采用随机效应meta回归分析患病率与海拔的关系。
主要发现
- 海拔可预测AMS,解释研究间28%的异质性。
- 海拔每升高1000米(2500米以上),AMS患病率增加13%(95%CI 9.5%-17%)。
- CFS日常活动中度至重度受限:阳性似然比3.2(95%CI 1.4-7.2),特异性67%(95%CI 37%-97%)。
- CFS无受限至轻度受限:阴性似然比0.30(95%CI 0.22-0.39),敏感性82%(95%CI 77%-87%)。
关键数值与推荐
- LLQS≥5作为AMS参考标准。
- AMS-C≥0.7表示AMS,CFS≥2表示AMS。
- VAS(O)采用各种阈值。
- CFS询问单一问题:总体而言,如果有任何症状,它们如何影响你的活动(序数尺度0-3)?
临床怎么用
- 临床和旅行环境中,CFS是最简单的工具。
- 评估报告日常活动中度至重度受限(CFS≥2)的高海拔旅行者时,应使用LLQS评估AMS严重程度。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acute mountain sickness (AMS) affects more than 25% of individuals ascending to 3500 m (11 500 ft) and more than 50% of those above 6000 m (19 700 ft). AMS may progress from nonspecific symptoms to life-threatening high-altitude cerebral edema in less than 1% of patients. It is not clear how to best diagnose AMS. OBJECTIVE: To systematically review studies assessing the accuracy of AMS diagnostic instruments, including the visual analog scale (VAS) score, which quantifies the overall feeling of sickness at altitude (VAS[O]; various thresholds), Acute Mountain Sickness-Cerebral score (AMS-C; ≥0.7 indicates AMS), and the clinical functional score (CFS; ≥2 indicates AMS) compared with the Lake Louise Questionnaire Score (LLQS; score of ≥5). DATA EXTRACTION AND SYNTHESIS: Searches of MEDLINE and EMBASE from inception to May 2017 identified 1245 publications of which 91 were suitable for prevalence analysis (66 944 participants) and 14 compared at least 2 instruments (1858 participants) using a score of 5 or greater on the LLQS as a reference standard. To determine the prevalence of AMS for establishing the pretest probability of AMS, a random-effects meta-regression was performed based on the reported prevalence of AMS as a function of altitude. MAIN OUTCOMES AND MEASURES: AMS prevalence, likelihood ratios (LRs), sensitivity, and specificity of screening instruments. RESULTS: The final analysis included 91 articles (comprising 66 944 study participants). Altitude predicted AMS and accounted for 28% of heterogeneity between studies. For each 1000-m (3300-ft) increase in altitude above 2500 m (8200 ft), AMS prevalence increased 13% (95% CI, 9.5%-17%). Testing characteristics were similar for VAS(O), AMS-C, and CFS vs a score of 5 or greater on the LLQS (positive LRs: range, 3.2-8.2; P = .22 for comparisons; specificity range, 67%-92%; negative LRs: range, 0.30-0.36; P = .50 for comparisons; sensitivity range, 67%-82%). The CFS asks a single question: "overall if you had any symptoms, how did they affect your activity (ordinal scale 0-3)?" For CFS, moderate to severe reduction in daily activities had a positive LR of 3.2 (95% CI, 1.4-7.2) and specificity of 67% (95% CI, 37%-97%); no reduction to mild reduction in activities had a negative LR of 0.30 (95% CI, 0.22-0.39) and sensitivity of 82% (95% CI, 77%-87%). CONCLUSIONS AND RELEVANCE: The prevalence of acute mountain sickness increases with higher altitudes. The visual analog scale for the overall feeling of sickness at altitude, Acute Mountain Sickness-Cerebral, and clinical functional score perform similarly to the Lake Louise Questionnaire Score using a score of 5 or greater as a reference standard. In clinical and travel settings, the clinical functional score is the simplest instrument to use. Clinicians evaluating high-altitude travelers who report moderate to severe limitations in activities of daily living (clinical functional score ≥2) should use the Lake Louise Questionnaire Score to assess the severity of acute mountain sickness.
引用
- Meier D, Collet TH, Locatelli I, et al. Does This Patient Have Acute Mountain Sickness?: The Rational Clinical Examination Systematic Review. JAMA. 2017. PMID: 29136449. doi:10.1001/jama.2017.16192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。